Literature DB >> 11669497

Prognostic implication of pretreatment plasma/serum concentration of Epstein-Barr virus DNA in nasopharyngeal carcinoma.

Y M Lo1.   

Abstract

Recently, much interest has been focused on the diagnostic application and biology of tumor-derived DNA in the plasma and serum of cancer patients. Such interest has resulted in the demonstration of Epstein-Barr virus (EBV) DNA in the plasma/serum of patients with nasopharyngeal carcinoma (NPC). Using quantitative real-time polymerase chain reaction (PCR) technology, circulating EBV DNA has been found not only to correlate with disease staging, but also to provide additional prognostic information. Following treatment, circulating EBV DNA analysis has been shown to provide useful information for the monitoring for tumor recurrence. In addition to NPC, it is envisaged that circulating DNA technology will find wide applications in the detection and monitoring of many other types of malignancies.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11669497     DOI： 10.1016/s0753-3322(01)00083-x

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN： 0753-3322            Impact factor:   6.529


  9 in total

Review 1.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  CpG island methylator phenotype of multigene in serum of sporadic breast carcinoma.

Authors:  Feng Jing; Wang Yuping; Chen Yong; Luo Jie; Lu Jun; Tang Xuanbing; Hu Lihua
Journal:  Tumour Biol       Date:  2010-05-20

3.  Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies.

Authors:  H Yang; K Yang; A Khafagi; Y Tang; T E Carey; A W Opipari; R Lieberman; P A Oeth; W Lancaster; H P Klinger; A O Kaseb; A Metwally; H Khaled; D M Kurnit
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-24       Impact factor: 11.205

Review 4.  DNA methylation changes in prostate cancer: current developments and future clinical implementation.

Authors:  Mohammad Obaidul Hoque
Journal:  Expert Rev Mol Diagn       Date:  2009-04       Impact factor: 5.225

Review 5.  Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications.

Authors:  Jennifer L Hunt; Leon Barnes; James S Lewis; Magdy E Mahfouz; Pieter J Slootweg; Lester D R Thompson; Antonio Cardesa; Kenneth O Devaney; Douglas R Gnepp; William H Westra; Juan P Rodrigo; Julia A Woolgar; Alessandra Rinaldo; Asterios Triantafyllou; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-07       Impact factor: 2.503

6.  Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079).

Authors:  B B Y Ma; B C Goh; W T Lim; E P Hui; E H Tan; G de Lima Lopes; K W Lo; L Li; H Loong; N R Foster; C Erlichman; A D King; M K M Kam; S F Leung; K C Chan; A T C Chan
Journal:  Invest New Drugs       Date:  2015-06-19       Impact factor: 3.651

7.  Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma.

Authors:  K C Allen Chan
Journal:  Chin J Cancer       Date:  2014-11-21

8.  Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma.

Authors:  Anussara Prayongrat; Chakkapong Chakkabat; Danita Kannarunimit; Pokrath Hansasuta; Chawalit Lertbutsayanukul
Journal:  J Radiat Res       Date:  2017-07-01       Impact factor: 2.724

9.  Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology.

Authors:  José A González-Masiá; Damián García-Olmo; Dolores C García-Olmo
Journal:  Onco Targets Ther       Date:  2013-07-08       Impact factor: 4.147
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.